Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: A mobile dedicated cable for a medical Computed Tomography (CT) bed, having an inner sheath layer, a first Teflon® belt, a signal cable layer, a second Teflon® belt, a braided layer and an outer sheath layer, which are coaxially arranged from inside to outside in sequence. The inner sheath layer has a PVC filling strip wrapped by the first Teflon® belt, and a plurality of bulletproof filaments arranged in the center of the PVC filling strip. The signal cable layer has a plurality of signal lines evenly arranged therein, each of which are circumscribed with the first Teflon® belt and the second Teflon® belt, and with two signal lines adjacent thereto.

Abstract: The present invention discloses a mobile dedicated cable for a medical Computed Tomography (CT) bed, comprising an inner sheath layer, a first Teflon® belt, a signal cable layer, a second Teflon® belt, a braided layer and an outer sheath layer, which are coaxially arranged from inside to outside in sequence. The inner sheath layer comprises a PVC filling strip wrapped by the first Teflon® belt, and a plurality of bulletproof filaments arranged in the center of the PVC filling strip. The signal cable layer comprises a plurality of signal lines evenly arranged therein, each of which are circumscribed with the first Teflon® belt and the second Teflon® belt, and with two signal lines adjacent thereto. The cable of the invention has improved flexibility and working life, thereby being suitable for the medical CT bed.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: The present application provides use of an algal proteoglycan extract and a composition comprising the same in treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: Use of an algal proteoglycan extract and a composition comprising the same in the manufacture of a medicament for treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: Use of an algal proteoglycan extract and a composition comprising the same in the manufacture of a medicament for treating or preventing tumor, pain, inflammation or diseases mediated by inflammatory factors.

Abstract: Phospholipo-proteins which have been enzyme modified may be used as an emulsifier to improve the emulsion stability of frozen products, e.g., during the freeze thaw and vacuum cool processes. Especially preferred is use of the enzyme phospholipase A to modify egg yolk and to use the modified egg yolk as an emulsifier in frozen products. Creation of a more stable emulsion can be expected to improve the overall appearance of the final product both in the frozen state and after the product has been reheated. Although egg yolk is preferred, examples of other phospholipo-protein containing substances include casein, skim milk, buttermilk, whey, cream, soybean, yeast, whole egg, blood serum and wheat proteins. Egg yolk and/or other sources of phopholipo-protein can be subjected to the action of phospholipase A or other enzyme, and then the modified product incorporated into the products of the invention.

Abstract: Phospholipo-proteins which have been enzyme modified may be used as an emulsifier to improve the emulsion stability of frozen products, e.g., during the freeze thaw and vacuum cool processes. Especially preferred is use of the enzyme phospholipase A to modify egg yolk and to use the modified egg yolk as an emulsifier in frozen products. Creation of a more stable emulsion can be expected to improve the overall appearance of the final product both in the frozen state and after the product has been reheated. Although egg yolk is preferred, examples of other phospholipo-protein containing substances include casein, skim milk, buttermilk, whey, cream, soybean, yeast, whole egg, blood serum and wheat proteins.

Abstract: The present invention provides a pharmaceutical composition containing proteoglycan extracts of algae and a process for preparing proteoglycan extracts from the algae.